Utilization of genomic signatures to identify Fludarabine and Temsirolimus as candidate drugs with high efficacy to chemo-refractory endometrial cancers


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Baba, T; Kharma, B; Mandai, M; Yoshioka, Y; Hamanishi, J; Matsumura, N; Yamaguchi, K; Murphy, S; Konishi, I

Published Date

  • March 2012

Published In

Volume / Issue

  • 125 /

Start / End Page

  • S138 - S138

Published By

International Standard Serial Number (ISSN)

  • 0090-8258

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2011.12.338